Portugal Becomes First EU Member to Join Health AIs Global Regulatory Network, Advancing Responsible AI in Healthcare

On July 16, 2026, Portugal reaffirmed its commitment to responsible artificial intelligence (AI) governance in healthcare by becoming the first member of the HealthAI Global Regulatory Network. The goal of the collaboration between the Geneva-based charity HealthAI and Infirmed, Portugal's national authority for pharmaceuticals and health goods, is to improve global collaboration in the regulation of AI-powered healthcare solutions. As AI becomes a more significant component of contemporary healthcare systems, the effort reflects the growing necessity for nations to collaborate.

From medical imaging and disease diagnosis to clinical decision support, hospital administration, medication discovery, and remote patient monitoring, artificial intelligence is revolutionizing almost every facet of healthcare. These developments present new regulatory obstacles even though they have the potential to enhance patient outcomes and healthcare efficiency. Because AI models can constantly change due to software updates and new datasets, authorities must embrace more dynamic supervision methods in place of traditional approval procedures. To address these issues through international cooperation. Portugal's membership in the Global Regulatory Network is a significant step.

Portugal will get access to HealthAI's collaborative regulatory platform as part of the deal, which allows member nations to share technical know-how, regulatory experiences, and knowledge about AI-enabled healthcare solutions. Before evaluating comparable goods for their own markets, healthcare authorities can study the available evidence thanks to the platforms' global collection of AI technologies that have already passed regulatory scrutiny. This strategy encourages regulatory uniformity, lessens the need for repeated assessments, and facilitates the quicker yet safer adoption of cutting-edge medical technology.

The Global Regulatory Networks international incident monitoring system is another key component. Regulators can swiftly report and receive information concerning cybersecurity threats with unexpected AI performance safety concerns and the other problems related to AI-based medical products using these platforms. Real-time information exchange enables regulatory bodies to improve patient safety across borders and react to new threats more skillfully.

The European Union AI Act, which establishes extensive controls for high-risk AI uses, including healthcare technologies, is complemented by Portugal's decision. Strict guidelines for risk management cybersecurity human oversight transparency and ongoing monitoring are established by the law. HealthAI Global Regulatory Network offers useful cooperation that allows regulators to share knowledge and carry out these duties more effectively even if the AI Act provides the legislative basis.

AI-powered healthcare solutions keep getting better through machine learning and algorithm updates in contrast to conventional medical devices that usually stay the same after clearance. Because of this dynamic character, ongoing regulatory monitoring is crucial. Portugal will get access to global knowledge across the whole lifecycle of AI products from preliminary assessment to post-market monitoring, by joining the Global Regulatory Networks.

Along with the United Kingdom, India, Brazil, Singapore, Indonesia, Vietnam, Peru, Zambia, and the Philippines, Portugal is now one of an increasing number of nations taking part in the HealthAI effort. The growing network shows that it is becoming more widely acknowledged that national laws alone are insufficient for AI governance. Rather, creating universal norms that promote innovation while safeguarding people and healthcare systems is becoming increasingly dependent on international cooperation.

Infirmed claims that cooperation between regulatory bodies will strengthen oversight frameworks and increase public confidence in AI-enabled healthcare technology. Additionally, HealthAI stressed that Europe's involvement is especially important since EU regulations frequently have an impact on global healthcare policies and technological standards. Therefore, it is anticipated that Portugal's membership will help build globally coordinated techniques for regulating artificial intelligence in healthcare in addition to improving national healthcare.

Impact on the Healthcare Industry

According to Precedence Research, as hospitals, healthcare providers, and regulatory bodies concentrate on enhancing patient care, operational effectiveness, and clinical decision-making, artificial intelligence is being rapidly used in the healthcare sector. Diagnostics, medical imaging, disease prediction, individualized treatment planning, remote patient monitoring, and hospital workflow automation are all increasingly incorporating AI technologies. Standardized regulatory frameworks that guarantee patient safety, transparency, and ethical implementation are becoming more and more necessary as AI-enabled healthcare technology bolsters international regulatory cooperation. Portugal's decision to join Health AI's Global Regulatory Network helps this transition. The initiative is enacted to improve regulatory efficiency, accelerate responsible innovation, and increase confidence in AI solutions among healthcare providers, technology developers, and patients.

Impact on the Healthcare Artificial Intelligence Market

The global artificial intelligence (AI) in healthcare market size is valued at USD 36.96 billion in 2025 and is predicted to increase from USD 51.20 billion in 2026 to approximately USD 744.34 billion by 2035, expanding at a CAGR of 35.02% from 2026 to 2035.

Due to the rising investments in AI-powered diagnostics, predictive analytics, clinical decision support systems, robotics-assisted surgery, and personalized medicine, the worldwide healthcare artificial intelligence market is expanding significantly. AI is being actively used by healthcare organizations to improve patient outcomes, save operating costs, streamline hospital workflows, and increase diagnostic accuracy. It is anticipated that Portugal's involvement in HealthAI's Global Regulatory Network will help the sector by establishing a more uniform and transparent regulatory framework for AI-based medical products. Increased international collaboration among regulators can speed up the commercialization of reliable AI healthcare solutions in foreign markets, promote innovation, and simplify clearance processes.

Impact on the Healthcare IT Market

The global healthcare IT market size accounted for USD 880.56 billion in 2025 and is predicted to be worth around USD 3,715.34 billion by 2035, growing at a CAGR of 15.48% from 2026 to 2035.

According to Precedence Research, the more healthcare organizations engage in digital infrastructure, cloud-based healthcare platforms, health information systems, artificial intelligence, and data-driven clinical solutions, the more the worldwide healthcare IT industry grows gradually. Precedence research claims that the need for cutting-edge healthcare IT solutions is being driven globally by the increased emphasis on enhancing operational effectiveness, patient safety, and healthcare interoperability. By promoting uniform regulatory procedures for AI-enabled healthcare innovations, Portugal's involvement in Health AI’s Global Regulatory Network supports this change. The partnerships are anticipated to boost cross-border technology adoption, increase regulatory clarity, and motivate healthcare businesses to invest in safe, legal, and cutting-edge healthcare IT systems, all of which will promote the long-term expansion of the healthcare IT sector.

About HealthAI

A non-profit organization with headquarters in Geneva, HealthAI is committed to promoting the ethical, responsible, and safe application of AI in healthcare. To create globally standardized regulatory frameworks for AI-enabled medical solutions, the group works with governments, healthcare authorities, international organizations, research institutes, and tech firms. HealthAI's Global Regulatory Network allows member nations to share regulatory knowledge, keep an eye on safety issues involving AI, and advance best practices for assessing and regulating AI solutions. Health AI seeks to promote responsible AI innovation while guaranteeing patient safety, regulatory transparency, and fair access to reliable healthcare solutions globally. It is backed by governments in Canada, the UK, Norway, and Singapore.